Target intelligence / Profile preview

Skin plumping

Molecular classification
Glycosaminoglycan, Extracellular matrix protein, Cell surface receptor, Peptide
01

Overview

Skin plumping refers to a complex physiological state of the skin characterized by high hydration levels, significant dermal volume, and structural integrity, rather than representing a single discrete molecular target. The primary biological driver of this effect is Hyaluronic acid (HA), a glycosaminoglycan that acts as a potent humectant by binding up to 1,000 times its weight in water within the extracellular matrix (ECM) [1, 13, 14]. This hygroscopic action provides the turgor and volume necessary for a smooth, firm appearance, while structural proteins like Collagen and Elastin provide the mechanical scaffolding that prevents sagging [4, 18]. At the molecular level, the interaction between HA and its principal cell-surface receptor, CD44, is essential for regulating HA homeostasis, keratinocyte proliferation, and the maintenance of the epidermal barrier [6, 9]. Therapeutic strategies targeting this state include the administration of exogenous HA through fillers or topical serums, and the use of retinoids or bioactive peptides to stimulate the endogenous synthesis of structural ECM components [11, 15, 16]. Clinically, the loss of skin plumpness is a hallmark of both intrinsic and extrinsic aging, often characterized by increased matrix metalloproteinase activity and diminished glycosaminoglycan production [2, 11, 13].

Other names
Skin volumizationDermal fullnessSkin firmingSkin turgiditySkin rejuvenation
02

Mechanism of action

Enhancement of dermal and epidermal volume through hygroscopic water retention and the stimulation of fibroblast-mediated synthesis of structural proteins (collagen, elastin) and glycosaminoglycans.

03

Biological functions

Hydration and water retentionExtracellular matrix organizationCell proliferation and differentiationStructural support and scaffoldingTissue repair and wound healing
04

Disease associations

Skin agingXerosis (Skin dryness)Atrophy of the skinWound healingAtopic dermatitis
05

Safety considerations

Hypersensitivity and allergic reactionsRetinoid-induced irritation (dermatitis)Granuloma formation (with injectable fillers)Risk of vascular occlusion (with injectable fillers)Edema at the site of application/injection
06

Interacting drugs

Hyaluronic acid

7 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Dermal thickness (Ultrasound)Dermal collagen densitySkin elasticity (Cutometry/R-values)Hyaluronic acid concentration (Skin biopsy/staining)

Beyond the preview

Go deeper on Skin plumping.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin plumping.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call